ProQR Therapeutics NV
NASDAQ:PRQR
ProQR Therapeutics NV
Cash from Investing Activities
ProQR Therapeutics NV
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ProQR Therapeutics NV
NASDAQ:PRQR
|
Cash from Investing Activities
€4.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pharming Group NV
AEX:PHARM
|
Cash from Investing Activities
-$129.4m
|
CAGR 3-Years
-102%
|
CAGR 5-Years
-100%
|
CAGR 10-Years
N/A
|
|
Uniqure NV
NASDAQ:QURE
|
Cash from Investing Activities
-$205.7m
|
CAGR 3-Years
-179%
|
CAGR 5-Years
-118%
|
CAGR 10-Years
-39%
|
|
argenx SE
XBRU:ARGX
|
Cash from Investing Activities
$308.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merus NV
NASDAQ:MRUS
|
Cash from Investing Activities
-$27m
|
CAGR 3-Years
-163%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
N
|
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
|
Cash from Investing Activities
€715k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ProQR Therapeutics NV's Cash from Investing Activities?
Cash from Investing Activities
4.3m
EUR
Based on the financial report for Dec 31, 2023, ProQR Therapeutics NV's Cash from Investing Activities amounts to 4.3m EUR.